A Randomised, Double-blind Trial to Assess the Incidence of Endometrial Changes with ARIMIDEX™ Alone, NOLVADEX™ Alone, or ARIMIDEX and NOLVADEX in Combination, When Used as Adjuvant Treatment for Breast Cancer in Postmenopausal Women

For 1033IC/0029 - Several sets of results are provided as follows: